Japanese Drug Makers See Cancer Painkiller Sales In Health Plan Change
This article was originally published in PharmAsia News
Executive Summary
Several Japanese drug makers are focusing on developing painkillers for certain cancers to take advantage of changes in Japan's health insurance system set for this month